 The use of neo-adjuvant systemic therapy in women recently diagnosed with breast cancer is growing in popularity based on its proven benefit 1. Pre-operative chemotherapy not only can assist in regards to breast conservation therapy 2 but data suggest prognostic benefits in those subset of patients obtaining complete pathological response 3,4 . 